Literature DB >> 17668154

Association of Rpn10 with high molecular weight complex is enhanced during retinoic acid-induced differentiation of neuroblastoma cells.

Yoko Tayama1, Hiroyuki Kawahara, Ryosuke Minami, Masumi Shimada, Hideyoshi Yokosawa.   

Abstract

The ubiquitin-binding Rpn10 protein serves as an ubiquitin receptor that delivers client proteins to the 26S proteasome, the protein degradation complex. It has been suggested that the ubiquitin-dependent protein degradation is critical for neuronal differentiation and for preventing neurodegenerative diseases. Our previous study indicated the importance of Rpn10 in control of cellular differentiation (Shimada et al., Mol Biol Cell 17:5356-5371, 2006), though the functional relevance of Rpn10 in neuronal cell differentiation remains a mystery to be uncovered. In the present study, we have examined the level of Rpn10 in a proteasome-containing high molecular weight (HMW) protein fraction prepared from the mouse neuroblastoma cell line Neuro2a. We here report that the protein level of Rpn10 in HMW fraction from un-differentiated Neuro2a cells was significantly lower than that of other cultured cell lines. We have found that retinoic acid-induced neural differentiation of Neuro2a cells significantly stimulates the incorporation of Rpn10 into HMW fractions, although the amounts of 26S proteasome subunits were not changed. Our findings provide the first evidence that the modulation of Rpn10 is linked to the control of retinoic acid-induced differentiation of neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17668154     DOI: 10.1007/s11010-007-9553-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  40 in total

Review 1.  The proteasome, a novel protease regulated by multiple mechanisms.

Authors:  G N DeMartino; C A Slaughter
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

Review 2.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  Basic Medical Research Award. The ubiquitin system.

Authors:  A Hershko; A Ciechanover; A Varshavsky
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

4.  Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain.

Authors:  Eri Sakata; Yoshiki Yamaguchi; Eiji Kurimoto; Jun Kikuchi; Shigeyuki Yokoyama; Shingo Yamada; Hiroyuki Kawahara; Hideyoshi Yokosawa; Nobutaka Hattori; Yoshikuni Mizuno; Keiji Tanaka; Koichi Kato
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

Review 5.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

6.  A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3.

Authors:  M H Glickman; D M Rubin; O Coux; I Wefes; G Pfeifer; Z Cjeka; W Baumeister; V A Fried; D Finley
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

7.  Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity.

Authors:  John F Staropoli; Caroline McDermott; Cécile Martinat; Brenda Schulman; Elena Demireva; Asa Abeliovich
Journal:  Neuron       Date:  2003-03-06       Impact factor: 17.173

8.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

9.  Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome.

Authors:  Suzanne Elsasser; Devin Chandler-Militello; Britta Müller; John Hanna; Daniel Finley
Journal:  J Biol Chem       Date:  2004-04-26       Impact factor: 5.157

10.  Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.

Authors:  Joungil Choi; Allan I Levey; Susan T Weintraub; Howard D Rees; Marla Gearing; Lih-Shen Chin; Lian Li
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

View more
  1 in total

1.  Structure of ubiquitylated-Rpn10 provides insight into its autoregulation mechanism.

Authors:  Tal Keren-Kaplan; Lee Zeev Peters; Olga Levin-Kravets; Ilan Attali; Oded Kleifeld; Noa Shohat; Shay Artzi; Ori Zucker; Inbar Pilzer; Noa Reis; Michael H Glickman; Shay Ben-Aroya; Gali Prag
Journal:  Nat Commun       Date:  2016-10-04       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.